TNFSF10 and neoplasm: With additional preferable features such as stability, activity by oral administration, and penetration of the blood brain barrier, TIC10/ONC201 is a novel anti-tumor therapeutic agent that acts on tumor cells and microenvironment by inducing TRAIL.